Endotronix, Inc., a digital health, MedTech company dedicated to advancing the treatment of heart failure, today announced it has raised $45 million in Series D funding led by LSP, investing from its LSP Health Economics Fund 2. The round also included participation from Aperture Venture Partners, BioVentures Investors, Lumira Ventures, OSF Ventures, Seroba Life Sciences, SV Health Investors, Wanxiang Healthcare Investments, and an unnamed corporate strategic investor.The medtech startups plans
Read More
Endotronix
Endotronix Nabs $12M to Expand Wireless Pulmonary Artery Sensor
Endotronix, Inc., a digital health medtech company providing innovative solutions for patients with advanced heart failure, today announced that it has entered into a $12 million term loan agreement with Silicon Valley Bank (SVB). The financing comes after a successful $32 million Series C round last July that included BioVentures Investors, SV Life Sciences (SVLS), Lumira Capital, Aperture Venture Partners, OSF Ventures, existing investors, and a corporate strategic investor. The startup plans
Read More
Endotronix Nabs $32M for Wireless Pulmonary Artery Sensor
Endotronix, a digital health startup developing a implantable, wireless pulmonary artery sensor for patients suffering from advanced heart failure has raised $32 million in Series C funding. Participating investors in the round include BioVentures Investors, SV Life Sciences (SVLS), Lumira Capital, Aperture Venture Partners, and OSF Ventures along with existing investors and a corporate strategic investor. The company plans to use the funding from the round to support the safety and feasibility
Read More
